Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
AMLX —
AMYLYX PHARMACEUTICALS INC
CUSIP: 03237H101 · Held by 2 superinvestors · Combined value: $7,844,365
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $5,518,965 | 456,868 | ADD | +85,095 |
| 2 | Jim Simons | 0.0% | $2,325,400 | 192,500 | ADD | +172,600 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +172,600 | +867.3% |
| Ken Griffin | ADD | +85,095 | +22.9% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | REDUCE | -376,300 | -95.0% |
| Ken Griffin | REDUCE | -915,754 | -71.1% |
Who Owns AMLX? Superinvestor Holdings
AMYLYX PHARMACEUTICALS INC is held by 2 tracked superinvestors, with a combined position value of $8 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions.